SYNGENE.NS vs. 2269.HK
Compare and contrast key facts about Syngene International Limited (SYNGENE.NS) and WuXi Biologics (2269.HK).
Performance
SYNGENE.NS vs. 2269.HK - Performance Comparison
Loading graphics...
SYNGENE.NS vs. 2269.HK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SYNGENE.NS Syngene International Limited | -39.11% | -24.02% | 22.60% | 19.99% | -5.37% | -3.08% | 99.78% | 14.48% | 3.66% | 16.66% |
2269.HK WuXi Biologics | 14.20% | 86.87% | -38.43% | -50.19% | -28.50% | -7.98% | 219.55% | 102.76% | 24.85% | 52.87% |
Different Trading Currencies
SYNGENE.NS is traded in INR, while 2269.HK is traded in HKD. To make them comparable, the 2269.HK values have been converted to INR using the latest available exchange rates.
Returns By Period
In the year-to-date period, SYNGENE.NS achieves a -39.11% return, which is significantly lower than 2269.HK's 14.20% return.
SYNGENE.NS
- 1D
- 1.67%
- 1M
- -3.84%
- YTD
- -39.11%
- 6M
- -37.24%
- 1Y
- -44.70%
- 3Y*
- -12.48%
- 5Y*
- -6.48%
- 10Y*
- 7.78%
2269.HK
- 1D
- 0.00%
- 1M
- -4.98%
- YTD
- 14.20%
- 6M
- -13.55%
- 1Y
- 43.54%
- 3Y*
- -5.79%
- 5Y*
- -16.04%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SYNGENE.NS vs. 2269.HK — Risk / Return Rank
SYNGENE.NS
2269.HK
SYNGENE.NS vs. 2269.HK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Syngene International Limited (SYNGENE.NS) and WuXi Biologics (2269.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SYNGENE.NS | 2269.HK | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.45 | 0.83 | -2.27 |
Sortino ratioReturn per unit of downside risk | -2.05 | 1.32 | -3.37 |
Omega ratioGain probability vs. loss probability | 0.72 | 1.19 | -0.46 |
Calmar ratioReturn relative to maximum drawdown | -0.94 | 1.28 | -2.22 |
Martin ratioReturn relative to average drawdown | -2.06 | 3.16 | -5.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SYNGENE.NS | 2269.HK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.45 | 0.83 | -2.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.24 | -0.25 | +0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.27 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.36 | -0.04 |
Correlation
The correlation between SYNGENE.NS and 2269.HK is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SYNGENE.NS vs. 2269.HK - Dividend Comparison
SYNGENE.NS's dividend yield for the trailing twelve months is around 0.32%, while 2269.HK has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
SYNGENE.NS Syngene International Limited | 0.32% | 0.19% | 0.15% | 0.18% | 0.17% | 0.00% | 0.00% | 0.16% | 0.18% | 0.18% | 0.18% |
2269.HK WuXi Biologics | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SYNGENE.NS vs. 2269.HK - Drawdown Comparison
The maximum SYNGENE.NS drawdown since its inception was -58.78%, smaller than the maximum 2269.HK drawdown of -92.11%. Use the drawdown chart below to compare losses from any high point for SYNGENE.NS and 2269.HK.
Loading graphics...
Drawdown Indicators
| SYNGENE.NS | 2269.HK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.78% | -92.95% | +34.17% |
Max Drawdown (1Y)Largest decline over 1 year | -47.85% | -28.29% | -19.56% |
Max Drawdown (5Y)Largest decline over 5 years | -58.78% | -92.95% | +34.17% |
Max Drawdown (10Y)Largest decline over 10 years | -58.78% | — | — |
Current DrawdownCurrent decline from peak | -58.10% | -75.98% | +17.88% |
Average DrawdownAverage peak-to-trough decline | -13.35% | -42.31% | +28.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.70% | 14.73% | +6.97% |
Volatility
SYNGENE.NS vs. 2269.HK - Volatility Comparison
The current volatility for Syngene International Limited (SYNGENE.NS) is 12.37%, while WuXi Biologics (2269.HK) has a volatility of 14.50%. This indicates that SYNGENE.NS experiences smaller price fluctuations and is considered to be less risky than 2269.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SYNGENE.NS | 2269.HK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.37% | 14.50% | -2.13% |
Volatility (6M)Calculated over the trailing 6-month period | 22.80% | 31.30% | -8.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.10% | 54.28% | -23.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.97% | 66.82% | -38.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.38% | 60.25% | -30.87% |
Financials
SYNGENE.NS vs. 2269.HK - Financials Comparison
This section allows you to compare key financial metrics between Syngene International Limited and WuXi Biologics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities